Back to search
Atypical Nevi
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Atypical Nevi trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Atypical Nevi trials you may qualify forThis research will have a significant impact on the overall management of those cancer patients and their family members who are at risk for hereditary cancer d…
This study will investigate how genetic and environmental factors contribute to the development of melanoma, a type of skin cancer, and related conditions. Ind…
This study will examine the impact of anti-programmed cell death 1 (PD1) therapy given in the approved adjuvant therapeutic regimens upon the morphologic, histo…
This observational, prospective cohort study aims to evaluate the diagnostic relevance of Reflectance Confocal Microscopy (RCM) features in atypical melanocytic…
Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be res…
The investigators' hypothesis is that cutaneous melanoma, melanoma in situ, dysplastic nevi and benign nevi all differ in not only clinical characteristics but…
The long-term goal of our PIC is to develop effective strategies that can be applied clinically at the point-of-care to prevent, intercept, or detect PDAC at an…
This is a new protocol to analyze how the use of the Sklip System enables laypersons to safely triage self-selected pigmented skin lesions of concern (PSLCs) fr…
The purpose of this study is to find out whether the Nevisense device can provide useful information about atypical moles to complement the usual assessments do…